Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PARITAPREVIR vs PAZOPANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PARITAPREVIR vs PAZOPANIB: Safety Overview

Metric PARITAPREVIR PAZOPANIB
Total FAERS Reports 202 21,208
Deaths Reported 16 5,612
Death Rate 7.9% 26.5%
Hospitalizations 43 4,347
Average Patient Age 61.9 yrs 61.2 yrs
% Female Patients 35.7% 41.2%
FDA Approval Date N/A Apr 23, 2024
Manufacturer N/A Golden State Medical Supply, Inc.
Route N/A ORAL
Marketing Status N/A Prescription